Sherwood J B, Goldwasser E
Blood. 1979 Oct;54(4):885-93.
We describe the development of a radioimmunoassay (RIA) for erythropoietin. Antisera were raised in rabbits with an impure human urinary erythropoietin preparation used as immunogen, but with pure human erytropoietin serving as the labeled antigen in the RIA and as a primary standard. The immunoreactivity of erythropoietin is not altered significantly by the mode of labeling with radioiodine, even though the biologic activity is lost. With this method, it is possible to detect 2--3 mU of erythropoietin in a volume of 0.1--0.3 ml. Therefore, the method can be used for detection of normal and subnormal serum titers as well as elevated titers. RIA for erythropoietin does not distinguish between the native (active in vivo) and the asialo form (inactive in vivo) and cannot yet be used for routine monitoring of crude fractions during purification.
我们描述了一种促红细胞生成素放射免疫测定法(RIA)的开发。用不纯的人尿促红细胞生成素制剂作为免疫原在兔体内产生抗血清,但在RIA中使用纯人促红细胞生成素作为标记抗原并作为主要标准品。尽管生物活性丧失,但促红细胞生成素的免疫反应性不会因放射性碘标记方式而发生显著改变。用这种方法,在0.1至0.3毫升体积中可以检测到2至3毫单位的促红细胞生成素。因此,该方法可用于检测正常和低于正常水平的血清滴度以及升高的滴度。促红细胞生成素的RIA无法区分天然形式(在体内有活性)和去唾液酸形式(在体内无活性),并且目前还不能用于纯化过程中粗分级分的常规监测。